365 related articles for article (PubMed ID: 8552399)
1. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
Kataoka K; Noda M; Nishizawa M
Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
[TBL] [Abstract][Full Text] [Related]
2. c-Jun inhibits NF-E2 transcriptional activity in association with p18/maf in Friend erythroleukemia cells.
Francastel C; Augery-Bourget Y; Prenant M; Walters M; Martin DI; Robert-Lézénès J
Oncogene; 1997 Feb; 14(7):873-7. PubMed ID: 9047395
[TBL] [Abstract][Full Text] [Related]
3. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor.
Kataoka K; Igarashi K; Itoh K; Fujiwara KT; Noda M; Yamamoto M; Nishizawa M
Mol Cell Biol; 1995 Apr; 15(4):2180-90. PubMed ID: 7891713
[TBL] [Abstract][Full Text] [Related]
4. Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif.
Toki T; Itoh J; Kitazawa J; Arai K; Hatakeyama K; Akasaka J; Igarashi K; Nomura N; Yokoyama M; Yamamoto M; Ito E
Oncogene; 1997 Apr; 14(16):1901-10. PubMed ID: 9150357
[TBL] [Abstract][Full Text] [Related]
5. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
Kerppola TK; Curran T
Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
[TBL] [Abstract][Full Text] [Related]
6. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
7. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins.
Kerppola TK; Curran T
Oncogene; 1994 Nov; 9(11):3149-58. PubMed ID: 7936637
[TBL] [Abstract][Full Text] [Related]
8. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins.
Igarashi K; Kataoka K; Itoh K; Hayashi N; Nishizawa M; Yamamoto M
Nature; 1994 Feb; 367(6463):568-72. PubMed ID: 8107826
[TBL] [Abstract][Full Text] [Related]
9. Rat maf-related factors: the specificities of DNA binding and heterodimer formation.
Matsushima-Hibiya Y; Nishi S; Sakai M
Biochem Biophys Res Commun; 1998 Apr; 245(2):412-8. PubMed ID: 9571165
[TBL] [Abstract][Full Text] [Related]
10. [Study of rat maf-related gene products: recognition DNA sequences and heterodimer-formation].
Hibiya Y
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):69-83. PubMed ID: 9086364
[TBL] [Abstract][Full Text] [Related]
11. mafA, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells.
Benkhelifa S; Provot S; Lecoq O; Pouponnot C; Calothy G; Felder-Schmittbuhl MP
Oncogene; 1998 Jul; 17(2):247-54. PubMed ID: 9674710
[TBL] [Abstract][Full Text] [Related]
12. Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain.
Fujiwara KT; Kataoka K; Nishizawa M
Oncogene; 1993 Sep; 8(9):2371-80. PubMed ID: 8361754
[TBL] [Abstract][Full Text] [Related]
13. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
14. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun.
Kataoka K; Noda M; Nishizawa M
Mol Cell Biol; 1994 Jan; 14(1):700-12. PubMed ID: 8264639
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of a dominant-negative mutant of c-Jun.
Brown PH; Chen TK; Birrer MJ
Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
[TBL] [Abstract][Full Text] [Related]
16. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
Kim S; Brown PH; Birrer MJ
Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
Morgan IM; Asano M; Håvarstein LS; Ishikawa H; Hiiragi T; Ito Y; Vogt PK
Oncogene; 1993 May; 8(5):1135-40. PubMed ID: 8479738
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene.
Andrews NC; Kotkow KJ; Ney PA; Erdjument-Bromage H; Tempst P; Orkin SH
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11488-92. PubMed ID: 8265578
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells.
Chuen CK; Li K; Yang M; Fok TF; Li CK; Chui CM; Yuen PM
J Lab Clin Med; 2004 Feb; 143(2):75-88. PubMed ID: 14966463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
